Agilent Technologies, Inc. $A Shares Purchased by Vaughan Nelson Investment Management L.P.

Vaughan Nelson Investment Management L.P. boosted its stake in Agilent Technologies, Inc. (NYSE:A) by 11.4% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 202,742 shares of the medical research company’s stock after purchasing an additional 20,750 shares during the period. Vaughan Nelson Investment Management L.P. owned about 0.07% of Agilent Technologies worth $27,587,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. AQR Capital Management LLC boosted its holdings in Agilent Technologies by 424.1% during the 2nd quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company’s stock valued at $240,956,000 after acquiring an additional 1,652,244 shares during the period. Ameriprise Financial Inc. increased its position in shares of Agilent Technologies by 132.2% during the second quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company’s stock worth $277,807,000 after acquiring an additional 1,340,161 shares during the period. Troy Asset Management Ltd increased its position in shares of Agilent Technologies by 74.3% during the second quarter. Troy Asset Management Ltd now owns 2,397,820 shares of the medical research company’s stock worth $282,967,000 after acquiring an additional 1,021,865 shares during the period. Ilex Capital Partners UK LLP acquired a new stake in shares of Agilent Technologies in the second quarter valued at $96,684,000. Finally, SG Americas Securities LLC boosted its holdings in Agilent Technologies by 3,091.1% in the fourth quarter. SG Americas Securities LLC now owns 808,215 shares of the medical research company’s stock valued at $109,974,000 after purchasing an additional 782,888 shares during the period.

Agilent Technologies Stock Performance

Shares of Agilent Technologies stock opened at $113.90 on Wednesday. The company has a quick ratio of 1.59, a current ratio of 2.07 and a debt-to-equity ratio of 0.44. Agilent Technologies, Inc. has a 52 week low of $96.43 and a 52 week high of $160.27. The firm’s 50 day moving average is $122.64 and its two-hundred day moving average is $134.79. The firm has a market capitalization of $32.19 billion, a P/E ratio of 25.14, a P/E/G ratio of 2.36 and a beta of 1.31.

Agilent Technologies (NYSE:A) last issued its earnings results on Wednesday, February 25th. The medical research company reported $1.36 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.37 by ($0.01). Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The company had revenue of $1.80 billion during the quarter, compared to analyst estimates of $1.81 billion. During the same quarter in the previous year, the company posted $1.31 EPS. The company’s quarterly revenue was up 7.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. Research analysts forecast that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 22nd. Stockholders of record on Tuesday, March 31st will be issued a $0.255 dividend. This represents a $1.02 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Tuesday, March 31st. Agilent Technologies’s payout ratio is presently 22.52%.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on the company. Weiss Ratings restated a “hold (c+)” rating on shares of Agilent Technologies in a report on Monday, December 29th. TD Cowen decreased their price objective on Agilent Technologies from $170.00 to $157.00 and set a “buy” rating for the company in a research note on Thursday, February 26th. Morgan Stanley cut their target price on shares of Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating on the stock in a research note on Tuesday, March 3rd. Barclays reduced their target price on shares of Agilent Technologies from $165.00 to $150.00 and set an “overweight” rating on the stock in a report on Thursday, February 26th. Finally, UBS Group decreased their price target on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research note on Thursday, February 26th. Two investment analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $161.20.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.